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Abstract
Introduction: Economic evaluations of tobacco control policies targeting adolescents are scarce. 
Few take into account real-world, large-scale implementation costs; few compare cost-effective-
ness of different policies across different countries. We assessed the cost-effectiveness of five to-
bacco control policies (nonschool bans, including bans on sales to minors, bans on smoking in 
public places, bans on advertising at points-of-sale, school smoke-free bans, and school education 
programs), implemented in 2016 in Finland, Ireland, the Netherlands, Belgium, Germany, Italy, and 
Portugal.
Methods: Cost-effectiveness estimates were calculated per country and per policy, from the State 
perspective. Costs were collected by combining quantitative questionnaires with semi-structured 
interviews on how policies were implemented in each setting, in real practice. Short-term effective-
ness was based on the literature, and long-term effectiveness was modeled using the DYNAMO-
HIA tool. Discount rates of 3.5% were used for costs and effectiveness. Sensitivity analyses 
considered 1%–50% short-term effectiveness estimates, highest cost estimates, and undiscounted 
effectiveness.
Findings: Nonschool bans cost up to €253.23 per healthy life year, school smoking bans up to 
€91.87 per healthy life year, and school education programs up to €481.35 per healthy life year. 
Cost-effectiveness depended on the costs of implementation, short-term effectiveness, initial 
smoking rates, dimension of the target population, and weight of smoking in overall mortality and 
morbidity.
Conclusions: All five policies were highly cost-effective in all countries according to the World 
Health Organization thresholds for public health interventions. Cost-effectiveness was preserved 
even when using the highest costs and most conservative effectiveness estimates.
Implications: Economic evaluations using real-world data on tobacco control policies imple-
mented at a large scale are scarce, especially considering nonschool bans targeting adolescents. 
We assessed the cost-effectiveness of five tobacco control policies implemented in 2016 in Finland, 
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Ireland, the Netherlands, Belgium, Germany, Italy, and Portugal. This study shows that all five pol-
icies were highly cost-effective considering the World Health Organization threshold, even when 
considering the highest costs and most conservative effectiveness estimates.
Introduction
In order to prevent tobacco-related mortality and morbidity, coun-
tries have been encouraged to adopt tobacco control policies (TCPs) 
targeting both adults and adolescents.1 Preventing smoking among 
adolescents is of particular interest, as smoking during adolescence is 
associated with smoking during adulthood. Two of three adolescents 
who smoke will continue to smoke in adulthood,2,3 and the odds 
of being a smoker are 2.1 times higher for male adults who started 
smoking before the age of 16, comparing to those who started after 
age 20.4 Raising prices of tobacco products, implementing smoking 
bans, smoking prevention programs, and cessation support have 
been recommended by public health institutions to reduce adult and 
adolescent smoking.1,2,5–7
From an economic perspective, TCPs have proved to be highly 
cost-effective, or even cost saving.5,8,9 Sixteen economic evaluations 
of TCPs targeting adolescents were identified in a recent system-
atic review,9 but only three evaluated school or nonschool bans (the 
latter includes bans on smoking in public places, bans on advertising 
at points-of-sale, or bans on sales to minors). Data were based on 
simulated scenarios or controlled interventions, which may not re-
flect the real-world, large-scale, or context-specific outcomes. Up-to-
date economic evaluation of policies adopted in the real world are 
needed to inform decision makers about which policies are more 
cost-effective, and to what extent these TCPs should be adopted or 
scaled up. It is fundamental to discuss how cost-effectiveness varies 
across countries, degree of implementation, and type of design,10 and 
what reasons may be behind these variations. Therefore, we evalu-
ated the cost-effectiveness of bans on smoking in public places, bans 
on sales to minors, bans on advertising at points-of-sale, bans on 
smoking in school premises, and school education programs. These 
five policies were selected as evidence suggests that they may reduce 
adolescents’ smoking,1,2,5–7 and are implemented, or due to be im-
plemented, in Finland, Ireland, the Netherlands, Germany, Belgium, 
Italy, and Portugal. These seven countries represent different stages 
of the tobacco epidemic,11 with prevalence of cigarette use in the last 
30 days among 15- to 16-year-old adolescents ranging from 13% 
in Ireland, 15% in Flanders (Belgium), 21% in Portugal, 22% in 
Finland, and 37% in Italy.12
In order to provide evidence on the cost-effectiveness of (1) 
real-world, large-scale implementation of TCPs, by (2) using 
context-specific data, while (3) comparing the cost-effectiveness 
across policies and (4) countries, this study estimated the cost-effect-
iveness of implementing the five above mentioned TCPs, from the 
State perspective. Economic evaluations were performed across 
seven European settings (Finland-Tampere, Ireland-Dublin, the 
Netherlands-Amersfoort, Germany-Hanover, Belgium-Namur, Italy-
Latina, and Portugal-Coimbra).
Methods
Cost Estimation
Cost data collection followed an “ingredients-based” approach.9,13,14 
This means that, when available, we identified the resources, quan-
tities, and unit values involved in the implementation of the five 
policies. We used the State perspective, which considered costs of 
implementation at a higher level, as those costs covered by the na-
tional state, and those incurred at a lower level by the local author-
ities (such as municipalities and food safety authorities) or by school 
administrations. We included costs on personnel, transportation, 
communication, equipment, material and supplies, and other rele-
vant costs, defined by market prices. These costs did not take into 
account shadow prices. In some cases, however, we could only ob-
tain total costs without a decomposition of these into quantify of 
resources and their prices. For example, communication costs were 
provided as a total, without information on the amount resources 
and the prices of each communication strategy. Supplementary Table 
1 presents these costs measures.
We collected implementation costs for the year of 2016 (2015–
2016 school year) in the seven countries represented by one city 
that participated in the SILNE-R project (Tampere-Finland, Dublin-
Ireland, Amersfoort-the Netherlands, Namur-Belgium, Hannover-
Germany, Latina-Italy, and Coimbra-Portugal).15 The SILNE-R 
project was a project financed by the European Commission, 
involving seven European countries, and carried out between 2015 
and 2018. This project aimed at creating fine grained evidence 
on how to enhance TCPs’ effectiveness and cost-effectiveness in 
preventing youth smoking. The article resulted from a work package 
devoted to analyzing the cost and cost-effectiveness of TCPs focusing 
the youths.
We used a quantitative questionnaire to gather data about the 
quantity and value for each ingredient, coupled with open questions 
about how interventions were performed in reality in each setting, 
and the number of adolescents covered (which informs us about the 
scale of implementation). Costs were collected at national, regional, 
local, or school level, depending on the level of implementation in 
each setting. We collected data from nine institutions for nonschool 
bans (one national-level institution for Belgium, Ireland, Portugal, 
and the Netherlands, one local level in Tampere-Finland, two local 
level in Hannover-Germany, one local level and other regional level 
in Latina-Italy), 21 for school bans (four schools in Hannover-
Gemany, three in Amersfoort-the Netherlands, Coimbra-Portugal, 
Namur-Belgium, Tampere-Finland, and two schools in Dublin-
Ireland, as one did not reply), and 19 for school programs (one na-
tional, one regional, and one local institution in Hannover-Germany, 
three schools in Amersfoort-the Netherlands, Coimbra-Portugal, 
Namur-Belgium and Tampere-Finland, one school- and one local-
level institution in Latina-Italy, and two schools in Dublin-Ireland, 
as one did not reply). TL collected data for Coimbra-Portugal and 
communicated throughout the whole period of data collection with 
SILNE-R project data collectors, who shared details about the data, 
institutions, and contexts. We multiplied the quantity of each ingre-
dient (person-hours, kilometers, equipment, etc.) by its unit cost (in 
euros), and then calculated its cost per 100 000 persons covered by 
the policy.
Total costs of nonschool bans were obtained by summing the 
costs of bans on smoking in public places, bans on sales to minors, 
and bans on advertising at points-of-sale in each country (except in 
Italy and Germany, where bans on advertising at points-of-sale were 
not implemented). We extrapolated the costs collected at school, 
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local, or regional level for the whole country, in order to provide 
country-level cost-effectiveness results. In the case of school bans 
and school education programs, a mean cost was calculated for each 
country. To obtain the total costs of a multi-strategy approach, we 
summed the costs of these five policies (or four, in the case of Italy 
and Germany). Costs had 2016 as reference year. For the sake of 
international comparison, all costs were adjusted for purchasing 
power parity.16 Purchasing power parity is used as a currency con-
version rate in order to level the costs according to the purchasing 
power of different countries.
Effectiveness Estimation: General Approach
We used the DYNAMO-HIA tool to estimate the long-term effect-
iveness of the different policies in the seven countries. This tool was 
developed to support the quantification components of health im-
pact assessment projects. It quantifies the long-term impact of short-
term changes in the prevalence, morbidity, and mortality of risk 
factors and related diseases in the whole population. It simulates the 
evolution of these risk factors, diseases’ morbidity, and mortality in 
a population, through a dynamic Markov-type multistate model that 
combines stochastic microsimulation to estimate the development of 
a risk factor exposure, and macrosimulation to project the impact 
of the risk factor exposure on disease incidence, mortality, and mor-
bidity overtime.17,18 This allows us to understand the health gains of 
an intervention (where the prevalence or transition of a certain risk 
factor is modified) to a reference scenario (no modification). It thus 
informs us on how many healthy life years (HLY) would be saved if 
a certain public health program were implemented.19,20 This model 
is explained in detail in Boshuizen et al.17 The model requires epi-
demiological data, elaboration of different scenarios, and validation. 
We detail these three aspects below.
Effectiveness Estimation: Empirical Data
This tool requires country-specific demographic data, namely popu-
lation size and future newborns, and epidemiological data on in-
cidence, prevalence, mortality, and relative risks of a given factor 
leading to a given disease or death, disaggregated by age and sex.21
Specifically, it requires country-specific data on prevalence, inci-
dence, disability, and excess mortality related to esophageal, breast, 
colorectal, oral, and lung cancer, chronic obstructive pulmonary 
disease, diabetes, ischemic heart disease and stroke, smoking, body 
mass index, and alcohol consumption. Most of these country-specific 
data were included on the software and refer to the populations of 
the early 2000s, which we used as background for these simulations 
because most TCPs were implemented after that date. For more de-
tails on the years of data used regarding the disease and risk factor 
parameters for each country, see DYNAMO-HIA data documen-
tation.21 We added epidemiological data that were missing on dia-
betes and ischemic heart disease for Portugal and Belgium. These 
data were extracted from the Portuguese National Health Survey, 
Portuguese National Statistics Institute,22 Belgium Standardized 
Procedures for Mortality Analysis,23 and Belgium Morbidity 
Report.24 Data sources and reference years related to smoking are 
presented in Supplementary Table 3.
Data on relative risks from risk factors and from diseases, for 
death, disability, or transitions between risk factors were obtained 
from the literature and extrapolated to all countries.21 These data 
were included in the current version of DYNAMO-HIA software 
package available at www.dynamo-hia.eu.21
Short-term effectiveness data corresponded to the relative re-
duction in youth smoking prevalence rates in the period after the 
implementation of the TCPs. The DYNAMO-HIA software defined 
a smoker as one who smokes at least 1 cigarette/day, or who had 
smoked at least 100 cigarettes in lifetime and keeps smoking.25 
Short-term data were estimated by calculating the mean relative 
prevalence reduction of current (daily or weekly) smoking as men-
tioned in peer-reviewed studies and reports, such as Brown et al.’s26 
systematic review, the National Cancer Institute Monographs 1927 
and 21,5 the National Institute for Health and Care Excellence re-
views,6,28 the Surgeon General report,2 and the International Agency 
for Research on Cancer report29 (more information on effectiveness 
data is available in Table 1).
Long-Term Effectiveness Estimation: Computing Different 
Scenarios
The simulation model estimated how short-term effects on smoking 
rates would in the long-term result in an increase in the number of 
HLY lived by the target population. It followed the whole popula-
tion alive at year 0, including all age groups from zero to 95 years 
old, until the last person of the cohort died. That is, the model 
adopted a lifelong time horizon, and followed the complete country 
populations alive at year 0 without the introduction of newborns 
in future years, to allow control over the total countries’ popula-
tion size. Although the cohort included and followed the complete 
population, the reduction in smoking prevalence was applied only to 
minors (17 years old or younger), who were the focus of our study. 
We computed several scenarios, specifying several short-term ef-
fectiveness results, against a baseline nonintervention scenario. We 
based our scenario on the assumption that the risks of initiation, 
reinitiation, or cessation in these cohorts did not change, that is, that 
the probability of transition between nonsmoker to smoker, smoker 
to former smoker, or former smoker to smoker did not change. 
Table 1.  Short-Term Effectiveness Estimates Reported in the Literature for Bans on Smoking in Public Places, Sales to Minors, 
Advertising at Point-of-Sale, Smoking in School Premises, School Education Programs (Minimum, Maximum, and Mean of All Values 
Reported)
Minimum effectiveness Maximum effectiveness Mean References
Bans on smoking in public placesa 0% 31.9% 11.35% 5,2,30–32
Bans on sales to minorsb 0% 50% 25.6% 5,28
Bans on advertising at points-of-saleb 0% 16% 8% 5,2,33
Bans on smoking in school premisesb 0% 11% 3.7% 5,29,32,34,35
School education programsb 0% 41.9% 9.99% [4,2,36]
These percentages correspond to the relative reduction in smoking prevalence rates after the implementation of the abovementioned policies.
aThese estimates were only measured among adults, as no data on adolescents were available.
bEstimates were measured among adolescents.
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Further assumptions from the DYNAMO-HIA software, unrelated 
to these scenarios, are documented elsewhere.37
Validity
Internal validity has been previously evaluated by the DYNAMO-
HIA team.17,18 External validity was assessed by discussing the extent 
to which the findings from the countries’ sample would be general-
izable to the whole countries populations, and to other countries.13
Cost-Effectiveness Analysis
Long-term effectiveness was calculated for the complete country 
population at year 0, but resulted from the reduction in smoking 
prevalence in those younger than 18, because we were only inter-
ested in assessing how the policies targeting adolescents smoking 
could affect the whole population in the long run.
Long-term cost estimates were calculated for a time horizon of 
18 years, until those aged 0 at year 0 reached 18 years old (excluding). 
This time horizon reflects the total number of years of implementa-
tion of these policies in the cohorts’ minors. We considered that these 
annual costs would not vary from year to year and discounted them 
at 3.5% annual rate.9,13 Long-term effectiveness estimates were also 
discounted at a 3.5% annual rate.
Cost estimates were then divided by the total number of HLY 
saved by the cohort, for nonschool bans, school bans, school 
programs, and all TCPs together.
Deterministic sensitivity analyses were performed to observe how 
cost-effectiveness estimates would change in face of variations in sev-
eral parameters as by (1) widening short-term effectiveness scenarios 
(with 1%, 2%, 3%, 5%, 20%, 30%, 40%, and 50% prevalence re-
duction), (2) using the highest costs reported for each policy instead 
of its mean estimates (Supplementary Table 4), (3) 3.5% discount 
rate on effectiveness (Supplementary Table 5), and (4) 3.5% and 5% 
discount rates on costs9 (Supplementary Tables 6 and 7).
Results
Costs
Costs were mostly dependent on the number of person-hours de-
voted to the implementation of these policies, and to the value per 
hour of personnel.
The three nonschool bans (bans on smoking at public places, bans 
on sales to minors, and bans on advertising at points-of-sale) were 
monitored and enforced simultaneously in Belgium, Finland, Ireland, 
and Portugal. For that reason, their costs are presented in an aggre-
gated form. Smoke monitoring was performed together with other 
areas (such as food safety or occupational health). Bans were imple-
mented at the local level in Finland, Germany, and Italy, and at the na-
tional level in the remaining countries. Costs varied between €2,612 
(Germany) and €74,107 (Finland) per 100 000 persons covered.
The bans on smoking at school premises were mostly imple-
mented at the local or school level by schools’ staff, by monitoring 
school breaks and providing educational talks with noncompliant 
students and their parents. As monitoring was performed simul-
taneously to the monitoring of misconduct, with no time or staff 
exclusively allocated to smoking prevention, opportunity costs for 
personnel were near zero, and we considered only costs with sanc-
tioning, or costs with material or equipment. Finnish informants re-
ported that as their students were usually compliant with the ban, no 
costs were allocated to enforce it. In the remaining countries mean 
costs varied between €7,839 (Germany) and €47,802 (Italy) per 100 
000 students covered.
Costs with school education programs included the number 
of person-hours, materials, and equipment needed to prepare and 
implement the educational activities. Mean costs varied between 
€64,546 and €512,175 per 100 000 students, in Ireland and Italy, re-
spectively. These programs were implemented at national or regional 
level in Germany, national and school level in the Netherlands, and 
regional and school level in Italy, covering a larger number of adoles-
cents (larger scale). In the remaining countries these programs were 
implemented at school level, at a smaller scale.
Effectiveness
Table 2 shows the number of HLY saved after the implementa-
tion of TCPs. The estimates varied between 291 HLY saved per 
100 000 persons covered in Portugal, for a 1% relative smoking 
prevalence reduction among adolescents, and 38 000 HLY saved 
per 100 000 persons covered in Ireland, for a 50% relative reduc-
tion. Supplementary Figure 9 exemplifies the 50-year modification 
of smoking prevalence in each country for three short-term effective-
ness scenarios (4%, 10%, and 26% relative prevalence reduction).
Cost-Effectiveness
Estimates of cost-effectiveness varied depending on the implementa-
tion costs in each setting, and on the values of long-term effective-
ness (Figure 1).
The implementation of nonschool smoking bans would cost, as-
suming 26%5,28 and 8%5,2,33 mean prevalence reductions, from €3.65 
to €11.86 per HLY saved in Germany, €17.82 to €57.80 per HLY 
in Ireland, €14.13 to €45.93 per HLY in Italy, €21.17 to €68.78 per 
HLY in Belgium, €26.02 to €84.63 per HLY in Portugal, €33.31 to 
€108.18 per HLY in the Netherlands, and €77.92 to €253.23 per 
HLY in Finland, respectively (Table 3).
The implementation of school smoking bans cost €12.67 per 
HLY in Germany, €13.79 per HLY in Ireland, €29.59 per HLY in 
the Netherlands, €35.46 per HLY in Belgium, €45.04 per HLY in 
Portugal, and €91.87 per HLY in Italy, assuming a 4% prevalence 
reduction.23,38–40 In Finland, as explained earlier, the implementation 
of the school smoking bans had no extra costs for the schools.
Table 2. PPP-Adjusted Costs Per 100 000 Persons Covered, for Year 0, for Each Type of Policy, and Long-Term Effectiveness for 1% 
Prevalence Reduction (HLY Saved Per 100 000 Inhabitants)
Netherlands Germany Portugal Finland Belgium Italy Ireland
Costs nonschool bans 36 659.84 2612.28 10 936.99 74 107.83 16 975.01 9940.24 19 883.12
Costs school bans 22 623.56 7839.86 15 484.54 0.00 21 153.11 47 802.22 9127.30
Costs school education programs 433 213.38 199 822.21 410 303.33 187 610.12 237 517.13 512 175.81 64 546.39
Long-term effectiveness for 1% prevalence reduction 761.55 495.78 291.25 659.19 552.83 398.43 771.85
HLY = healthy life years; PPP = purchasing power parity.
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The implementation of school education programs cost €37.55 
per HLY saved in Ireland, €108.24 per HLY in Finland, €130.63 per 
HLY in Germany, €160.78 per HLY in Belgium, €226.06 per HLY in 
the Netherlands, €394.84 per HLY in Italy, and €481.35 per HLY in 
Portugal, assuming a 10% prevalence reduction.2,4,36
The cost-effectiveness for lower effectiveness scenarios, as 1% 
prevalence reduction scenario, is less favorable, but still below €4,813 
per HLY (value for Portugal, 1% relative prevalence reduction, costs 
school education programs, 3.5% discount rate for costs and ef-
fectiveness). Threshold analysis demonstrated that the minimum 
short-term effectiveness for highly cost-effective interventions is 
situated between 0.12% in Ireland for school bans and 0.0003% 
in Italy for school programs (3.5% discount rate for costs and ef-
fectiveness) (Supplementary Table 8). Other deterministic sensitivity 
analyses were performed applying 3.5% discount rates only to ef-
fectiveness. In this case the costs per HLY became larger reaching 
€6568.98 per HLY for school education programs implemented in 
Portugal, for 1% prevalence reduction (Supplementary Table 5). 
The same occurred when using the highest cost estimates reported 
in each country for school bans and school education programs, in-
stead of their mean cost value: the costs per HLY became larger, but 
still less than €8371.47 per HLY for Portugal, for school education 
programs, for a 1% prevalence reduction and 3.5% discount rate for 
costs and effectiveness (Supplementary Table 4). Applying 3.5% and 
5% discount rate on costs was associated with better cost-effective-
ness values (Supplementary Tables 6 and 7), as we do not discount 
the benefits that mostly occur in the long run.
Discussion
Main Findings
The costs of all policies varied between €93,556 and €569,918 per 
100 000 persons covered, for Ireland and Italy, respectively, and 
varied according to the number of person-hours devoted to the pol-
icies’ implementation. Long-term effectiveness estimates varied ac-
cording to the variability of short-term effectiveness and ranged from 
about 1200 HLY saved per 100 000 persons covered in Portugal for 
the implementation of bans on smoking in school premises (consid-
ering a short-term 4% prevalence reduction), to about 20 000 HLY 
in Ireland for the implementation of nonschool bans (26% preva-
lence reduction).
Cost-effectiveness values were quite low in all countries (see 
Table 3). Compared to the nonintervention scenario, the incre-
mental cost-effectiveness ratio would be below €2500 per HLY for 
nonschool bans, below €500 per HLY for school bans, and below 
€5000 for school education programs, even assuming the worst 
effectiveness scenarios. Cost-effectiveness estimates varied across 
countries, with the largest discrepancy for nonschool bans, but 
threshold analysis demonstrated that the minimum short-term ef-
fectiveness for highly cost-effective interventions is situated below 
1% in all countries and policies.
Interpretation of Results
For all policies, cost-effectiveness ratios were situated much below 
the World Health Organization thresholds for public health inter-
ventions to be regarded as highly cost-effective.41 These thresh-
olds correspond to the gross domestic product per capita for each 
country, and varied between €22 500 in Portugal (lowest value) 
and €53 300 in Ireland (highest value) in 2016, according to the 
Organisation for Economic Co-operation and Development fig-
ures.42 Cost-effectiveness estimates were based on 1%–50% relative 
prevalence reduction scenarios, and even in the most conservative 
scenarios (1% relative prevalence reduction, highest costs, and 3.5% 
and 5% discount rates), the implementation of these policies re-
mained highly cost-effective.
Nevertheless, incremental cost-effectiveness results varied 
across policies. Bans were more cost-effective than school educa-
tion programs because they covered a larger scale, requiring smaller 
marginal costs, that is, minor additional costs of implementation for 
one additional person covered, for similar effectiveness estimates.38 
Cost-effectiveness results also varied across countries, depending on 
Figure 1. Cost-effectiveness of nonschool bans (A), school bans (B), school 
education programs (C) for 3.5% discount rate (purchasing power parity-
adjusted euros per healthy life years saved). The vertical bars mark the mean 
of all effectiveness results reported by the literature for each policy.
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the implementation costs, and long-term health gains. First, imple-
mentation costs depend on the intensity of implementation in each 
country, which depends on the staff devoted to monitoring and 
enforcing the policy, for example, in the case of nonschool bans.39 
Second, long-term effectiveness depends on the short-term effective-
ness, and on each country population characteristics (ie, smoking 
rates, population-target size, and weight of smoking on morbidity 
and mortality). Thus, the higher costs of implementation in Portugal, 
Italy, and the Netherlands may be due to high monitoring and sanc-
tioning efforts, but as long-term health gains were smaller in the first 
two countries than in the Netherlands, due to lower youth smoking 
rates at year 0,40 their cost-effectiveness ratios were much higher.
We defined the same short-term effectiveness estimates in all 
countries, as detailed data per country were absent. Still, it is likely 
that countries with higher efforts (and costs) of implementation 
would experience a greater effectiveness.10,43 Thus, cost-effectiveness 
results are possibly lower than our estimates in countries with higher 
implementation efforts devoted to nonschool bans.10 As an example, 
in Finland the cost-effectiveness ratio should be lower, moving to the 
right in Figure 1, whereas in Germany it should be higher, moving to 
the left. The case of Ireland, however, contradicts this, because lower 
cost-effectiveness ratios are related to lower costs of implementa-
tion of TCPs. Low costs were found despite being considered one of 
the countries with stronger efforts of implementation of TCPs.10 An 
explanation may derive from the coexistence of strong TCPs, such 
as high taxation, implemented for a long time, and high smoking 
de-normalization, which may have had an impact in the prevalence 
of smoking and on the number of noncompliant cases, leading not 
only to a higher effectiveness, and but also to the decrease of the 
number of person-hours needed for monitoring or sanctioning.
Although we estimated the cost-effectiveness of TCPs for a 
1%–50% range of short-term effectiveness and included the 0% 
prevalence reduction results to calculate the mean short-term effect-
iveness of these policies, we must acknowledge that some policies 
may be not effective. Bans that allow exceptions, that are not con-
sistently monitored or strongly enforced may have low effectiveness 
outcomes, especially in contexts where smoking is still normalized, 
with low public support for TCPs, or where minors’ social networks 
help to circumvent them.44 If the policy is not effective due to its 
weak implementation, it signifies that money was spent for a zero 
benefit. Thus, as previously mentioned, the cost-effectiveness of 
these policies depends upon the social, cultural, and epidemiological 
contexts,11 the mechanisms of implementation,45 and the contribu-
tion of other TCPs.5,46,47 Comprehensive policies, strongly enforced, 
coordinated and associated with significant rise in the price of to-
bacco products, health warnings, and access to smoking cessation, 
may enhance the effectiveness of each policy, lower their costs of 
implementation, and lead to greater cost-effectiveness.5,8,46,47 As an 
example, long-term and strong efforts in Finland to reduce smoking 
in the general population and in schools may have effectively led 
to reducing the number of noncompliant cases in schools, and also 
reducing the schools’ costs on educating and sanctioning students; 
the same has been suggested to happen in Ireland.39 Other comple-
mentary strategies were suggested44 to raise these policies’ effective-
ness: Banning smoking at school and surrounding areas may reduce 
adolescents’ access to tobacco from colleagues, raising parents 
consciousness of their role on smoking prevention, and strongly 
monitoring sales, or reducing the number of sales outlets to limit 
adolescents’ access to tobacco from commercial sources.
In the light of these results, the reluctance to implement TCPs in 
some countries, as revealed by Joossens et al.10 might seem surprising 
at first sight. For comparison, highly expensive drugs with very un-
favorable cost-effectiveness values have been approved in European 
countries, for example, for lung cancer treatment.48 One reason may 
be that TCPs represent short-term costs with mostly long-run bene-
fits, whereas acute treatments provide short-term gains; also, the 
so-called “rule of rescue” refers to decision makers and the popula-
tion preferring to spend money on a few identifiable people at risk 
of death, than to achieve larger life gains in the future, saving “stat-
istical lives.” 49
Strengths and Limitations
This study presents several limitations regarding data collection on 
costs, and short- and long-term effectiveness. First, the cost-effective-
ness of nonschool bans was assessed in an aggregated form, as costs 
were not available disaggregated by ban in most of our countries. 
Even though disaggregated estimates may be preferable for some 
purposes, public health institutions usually advocate their com-
bined implementation. Our results demonstrate that independently 
of being monitored and enforced simultaneously or separately, they 
are highly cost-effective. Second, these policies were collected from a 
sample of local or school-level institutions, as data were not always 
available at the national level and it would be unrealistic to estimate 
the costs from all schools or institutions from the entire country. In 
order to estimate the cost-effectiveness of these policies, local-level 
costs were extrapolated to the national level. Though, the data from 
the respective cities may not be entirely representative of their coun-
tries, and this extrapolation may under- or overestimate the costs 
and cost-effectiveness of these policies at national levels. In order to 
enhance the external validity of our estimates, we estimated mean 
values from several low and high socioeconomic status schools, and 
from cities with socioeconomic characteristics similar to the national 
Table 3. Cost-Effectiveness of Nonschool Bans, School Bans, and School Programs, Per Country (PPP-Adjusted Euros Per HLY)
Prevalence reduction (%) Netherlands Germany Portugal Finland Belgium Italy Ireland
Nonschool bans 8 108.18 11.86 84.63 253.23 68.78 45.93 57.80
11 78.72 8.62 61.59 183.72 50.04 33.41 42.12
26 33.31 3.65 26.02 77.92 21.17 14.13 17.82
School bans 4 29.59 12.67 45.04 (No costs) 35.46 91.87 13.79
School programs 10 226.06 130.63 481.35 108.24 160.78 394.84 37.55
To estimate the cost-effectiveness ratio, we divided the costs of implementation in each country by the number of HLY saved for the national population. These 
estimates are given for each assumed prevalence reduction value. As an example, the total costs of implementation of nonschool bans for the whole 18-year period 
in the Netherlands were €483 531.67 per 100 000 inhabitants, and the total number of HLY saved per 100 000 inhabitants by these bans (assuming a smoking 
prevalence reduction of 8%) would be 4469.65 HLY (both values were discounted at 3.5%); yielding a cost-effectiveness ratio of €108.18/HLY. HLY = healthy 
life years; PPP = purchasing power parity.
D
ow
nloaded from
 https://academ
ic.oup.com
/ntr/advance-article-abstract/doi/10.1093/ntr/ntz124/5539730 by Tam
pere U
niversity and U
niversity H
ospital user on 27 Septem
ber 2019
7Nicotine & Tobacco Research, 2019, Vol. XX, No. XX
average.14 In order to estimate cost-effectiveness under conservative 
cost-effectiveness scenarios, we used the highest costs reported in 
each country’s institution.
Third, we did not have access to the relative prevalence reduction 
of smoking among adolescents in all seven countries for each policy. 
Indeed, these TCPs were implemented for a long time, often together 
or with other policies, and their effectiveness was rarely estimated. 
Instead, we used the mean of the various effectiveness estimates that 
were presented in the literature. However, these published estimates 
had limitations including (1) variations in study designs and out-
come estimations, (2) variation in geographic reference population, 
which ranged from the local or regional to international levels, and 
(3) in the case of bans on smoking in public places data pertained to 
the adult population. Moreover, short-term effectiveness is likely to 
vary according to which effects are measured, the target population 
(adults or adolescents), the way in which TCPs are implemented, and 
a country’s stage in the tobacco epidemic. This is why we performed 
a sensitivity analysis in which we assumed a wide range of potential 
relative prevalence reduction estimates (from 1% to 50%).
Fourth, the estimation of long-term effectiveness was based on 
the modification of prevalence of smoking in adolescents. We did 
not modify risks for smoking initiation or cessation, as data were not 
available for all five TCPs. However, in a realistic scenario, the risks 
for smoking initiation and reinitiation would probably decrease 
after the intervention, and the risk for cessation would increase.19 
This means that our findings are likely conservative, and that more 
accurate effectiveness estimates would lead to even lower cost-effect-
iveness ratios.
Finally, we did not consider the healthcare costs related to the 
reduction of smoking. We opted to inform the decision maker about 
the cost-effectiveness directly related to these policies’ implementa-
tion, disregarding other future savings or expenditures. Hence, our 
results are quite conservative, and would have been even more favor-
able had we been able to incorporate health care savings.
Despite these limitations, our costs, effectiveness, and cost-effect-
iveness results were, overall, in line with the literature.9,19 Considering 
that cost-effectiveness ratios were quite similar and all much below 
the World Health Organization threshold, we believe that high 
cost-effectiveness results would be found in the entire countries, 
and in countries with epidemiological and economic backgrounds 
similar to these seven. A major strength of this study is real-world 
and context-specific data, which were used for costs and effective-
ness estimates, combined with numerous short-term effectiveness re-
sults from previous studies.
Conclusion
All five TCPs were highly cost-effective, in all seven countries and in 
all levels of implementation, even when considering the most con-
servative estimates. Large-scale interventions, such as smoking bans, 
were the most cost-effective interventions due to their lower costs of 
implementation per person. Decision makers should, therefore, be 
encouraged to implement smoking prevention policies, as we pre-
sented reasonable and evidence-based arguments on cost-effective 
adoption and adaptation of TCPs in seven real-world settings.
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